Top Markets
Coin of the day
Medlab Clinical Limited Medlab Clinical Limited

Medlab Clinical Limited

MDC
Classificação em ações #32245
Medlab Clinical Limited is an Australian biotechnology firm dedicated to the... Medlab Clinical Limited is an Australian biotechnology firm dedicated to the research, development, and initial commercialization of innovative pharmaceutical and nutraceutical products. Its pipeline features key drug candidates such as NanaBis, a buccal spray derived from cannabis oil extract, intended for use in oncology and pain management. Another significant candidate is NanoCBD, a buccal spray sourced from hemp oil extract, aimed at supporting mental well-being. A core innovation is NanoCelle, a proprietary sub-micron drug delivery platform that enables the direct passive diffusion of active pharmaceutical ingredients into the bloodstream through diverse administration methods including oral-buccal, sublingual, intranasal, and transdermal or topical applications. The company also extends its offerings to include virtual clinic services. Founded in 2012, Medlab Clinical Limited is headquartered in Botany, Australia.
Preço da ação
$4.65
Última sincronização: 2024-07-24
Valor de mercado
$10.63M
Variação (1 dia)
6.66%
Variação (1 ano)
0.00%
País
AU
Negociar Medlab Clinical Limited (MDC)

Categoria

EPS de Medlab Clinical Limited (MDC)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Medlab Clinical Limited, o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Medlab Clinical Limited de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$17.32 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH
- -
KR